Cargando…
Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach
INTRODUCTION AND HYPOTHESIS: Patients with recurrent urinary tract infection (rUTI) have limited knowledge of preventive strategies to lower the risk of UTI. We aimed to develop and test the feasibility of an eHealth system for women with rUTI, named myRUTIcoach, and explored the facilitators and ba...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682280/ https://www.ncbi.nlm.nih.gov/pubmed/37755525 http://dx.doi.org/10.1007/s00192-023-05634-x |
_version_ | 1785150947605872640 |
---|---|
author | Pat, J. J. Pape, C. C. E. T Steffens, M. G. Witte, L. P. W. Blanker, M. H. |
author_facet | Pat, J. J. Pape, C. C. E. T Steffens, M. G. Witte, L. P. W. Blanker, M. H. |
author_sort | Pat, J. J. |
collection | PubMed |
description | INTRODUCTION AND HYPOTHESIS: Patients with recurrent urinary tract infection (rUTI) have limited knowledge of preventive strategies to lower the risk of UTI. We aimed to develop and test the feasibility of an eHealth system for women with rUTI, named myRUTIcoach, and explored the facilitators and barriers related to its adoption. METHODS: We developed myRUTIcoach in a structured iterative process and tested its feasibility among 25 women with rUTI over 2 months. Subsequent questionnaires covered satisfaction, accessibility, and experiences with myRUTIcoach. A random selection of participants and relevant stakeholders took part in semi-structured interviews to explore adoption. Data were analyzed and elaborated using inductive and deductive approaches using the Non-adoption, Abandonment, Spread, Scale-up, and Sustainability (NASSS) framework. RESULTS: MyRUTIcoach was not only widely accepted but also facilitated communication with health care professionals (HCPs) and contributed to greater knowledge of rUTI. Women graded the system a mean of 8.0 (±0.6) out of 10, with 89% stating that they would recommend it to others. Patients indicated that self-management skills were the major facilitators and barriers related to adoption, whereas HCPs stated that the disconnect between myRUTIcoach and electronic health care records (EHRs) was the major barrier. CONCLUSIONS: This research describes the development and testing of myRUTIcoach for women with rUTI. Patients and HCPs reported high satisfaction and compliance with myRUTIcoach. However, adoption by the intended users is complex and influenced by all examined domains of the NASSS framework. We have already improved linkage to EHRs, but further optimization to meet patient needs may improve the effectiveness of this self-management tool for rUTI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00192-023-05634-x |
format | Online Article Text |
id | pubmed-10682280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106822802023-11-30 Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach Pat, J. J. Pape, C. C. E. T Steffens, M. G. Witte, L. P. W. Blanker, M. H. Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: Patients with recurrent urinary tract infection (rUTI) have limited knowledge of preventive strategies to lower the risk of UTI. We aimed to develop and test the feasibility of an eHealth system for women with rUTI, named myRUTIcoach, and explored the facilitators and barriers related to its adoption. METHODS: We developed myRUTIcoach in a structured iterative process and tested its feasibility among 25 women with rUTI over 2 months. Subsequent questionnaires covered satisfaction, accessibility, and experiences with myRUTIcoach. A random selection of participants and relevant stakeholders took part in semi-structured interviews to explore adoption. Data were analyzed and elaborated using inductive and deductive approaches using the Non-adoption, Abandonment, Spread, Scale-up, and Sustainability (NASSS) framework. RESULTS: MyRUTIcoach was not only widely accepted but also facilitated communication with health care professionals (HCPs) and contributed to greater knowledge of rUTI. Women graded the system a mean of 8.0 (±0.6) out of 10, with 89% stating that they would recommend it to others. Patients indicated that self-management skills were the major facilitators and barriers related to adoption, whereas HCPs stated that the disconnect between myRUTIcoach and electronic health care records (EHRs) was the major barrier. CONCLUSIONS: This research describes the development and testing of myRUTIcoach for women with rUTI. Patients and HCPs reported high satisfaction and compliance with myRUTIcoach. However, adoption by the intended users is complex and influenced by all examined domains of the NASSS framework. We have already improved linkage to EHRs, but further optimization to meet patient needs may improve the effectiveness of this self-management tool for rUTI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00192-023-05634-x Springer International Publishing 2023-09-27 2023 /pmc/articles/PMC10682280/ /pubmed/37755525 http://dx.doi.org/10.1007/s00192-023-05634-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Pat, J. J. Pape, C. C. E. T Steffens, M. G. Witte, L. P. W. Blanker, M. H. Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach |
title | Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach |
title_full | Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach |
title_fullStr | Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach |
title_full_unstemmed | Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach |
title_short | Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach |
title_sort | development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myruticoach |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682280/ https://www.ncbi.nlm.nih.gov/pubmed/37755525 http://dx.doi.org/10.1007/s00192-023-05634-x |
work_keys_str_mv | AT patjj developmentandfeasibilityofatelemedicinetoolforpatientswithrecurrenturinarytractinfectionmyruticoach AT papeccet developmentandfeasibilityofatelemedicinetoolforpatientswithrecurrenturinarytractinfectionmyruticoach AT steffensmg developmentandfeasibilityofatelemedicinetoolforpatientswithrecurrenturinarytractinfectionmyruticoach AT wittelpw developmentandfeasibilityofatelemedicinetoolforpatientswithrecurrenturinarytractinfectionmyruticoach AT blankermh developmentandfeasibilityofatelemedicinetoolforpatientswithrecurrenturinarytractinfectionmyruticoach |